humanized SMART Anti-IL-12 Antibody Uses, Dosage, Side Effects and more

The humanized anti-IL-12 antibody is an important addition to PDL's already strong pipeline of humanized antibodies being developed for the treatment of autoimmune diseases. SMART Anti-IL-12 Antibody was humanized at PDL from a murine anti-IL-12 antibody that was licensed, together with certain intellectual property related to anti-IL-12 therapy, from Hoffmann-La Roche Inc. IL-12 is a cytokine that may have considerable potential as a target in the therapy of autoimmune diseases.

Trade Name humanized SMART Anti-IL-12 Antibody
Generic humanized SMART Anti-IL-12 Antibody
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Uses

Investigated for use/treatment in autoimmune diseases and inflammatory disorders (unspecified).

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share